Related by context. All words. (Click for frequent words.) 79 RhuDex R 78 RhuDex ® 77 RhuDex ™ 73 RhuDex 73 thalidomide Thalomid 73 LymphoStat B belimumab 73 Panzem R 73 beta 1a 72 MAGE A3 ASCI 71 tramiprosate Alzhemed TM 71 dasatinib Sprycel ® 71 AAG geldanamycin analog 71 cetuximab Erbitux R 71 Aflibercept 71 SinuNase TM 71 hypoxia activated prodrug 71 essential thrombocythemia ET 70 Xeloda ® 70 orally administered inhibitor 70 polycythemia vera essential thrombocythemia 70 Mg Uk 70 2 methoxyestradiol 70 SinuNase ™ 70 Panzem R NCD 70 anti PlGF 70 refractory chronic lymphocytic 70 thetreatment 70 resistant hormone refractory 70 vapreotide acetate 70 INSPIRE Trial Phase III 70 baminercept 70 myelodysplastic myeloproliferative diseases 70 Peginterferon alfa 2b 70 sorafenib tablets 70 Daclizumab 69 gemcitabine Gemzar ® 69 humanised monoclonal antibody 69 Personalized Immunotherapy 69 MKC# MT 69 Systemic Sclerosis 69 receptor tyrosine kinase inhibitor 69 budesonide foam 69 Archexin 69 humanized interleukin 6 69 Azacitidine 69 toenail onychomycosis 69 Amgen Neulasta R 69 sorafenib Nexavar 69 GW# [003] 69 Tofacitinib 69 dasatinib Sprycel 69 PF # [002] 69 virus HCV protease inhibitor 69 Pharmacokinetics PK 69 CDP# 69 Velcade bortezomib 69 PEGylated Fab fragment 69 EndoTAGTM 1 69 Phase #b/#a clinical 69 Temsirolimus 69 FUSILEV enhances 69 PDE4 inhibitor 69 galiximab 69 CYT# potent vascular disrupting 69 humanized therapeutic 69 Safinamide 69 Ocrelizumab 68 IMiDs ® 68 reslizumab 68 Bezielle 68 etanercept Enbrel 68 IV Busulfex 68 pan HDAC inhibitor 68 IAP inhibitor 68 generation purine nucleoside 68 Fludara ® 68 octreotide implant 68 non nucleoside inhibitor 68 Hormone Refractory Prostate Cancer 68 LymphoStat B TM 68 prucalopride 68 formerly LymphoStat B 68 DEB# 68 XL# anticancer compounds 68 5 FU capecitabine 68 IL# PE#QQR 68 phase III isavuconazole 68 including eniluracil ADH 68 evaluating satraplatin 68 Initiate Clinical Trial 68 DDP# 68 Immunotherapeutic 68 relapsed MM 68 DCVax R 68 targeted radiotherapeutic 68 YONDELIS 68 ASONEP TM 68 Vidaza azacitidine 68 IMA# 68 erlotinib Tarceva ® 68 Crofelemer budesonide foam 68 EndoTAG TM -1 68 oral nucleoside analogue 68 Mg Usa 68 Xanafide 68 ara C 68 elotuzumab 68 gefitinib Iressa 68 somatostatin analog 68 myelofibrosis polycythemia vera 68 dimebon latrepirdine 68 Amgen Neulasta ® 68 SYN# 68 oral prodrug 68 multiple sclerosis psoriasis 68 nucleoside analog 68 PNP inhibitor 68 Abiraterone acetate 68 trastuzumab Herceptin R 68 Interferon beta 68 Annamycin 68 diarrhea predominant irritable 68 Vitaxin 67 corticosteroid dexamethasone 67 lexidronam injection 67 Pegloticase 67 RTP #i 67 alemtuzumab Campath 67 treat chronic sinusitis 67 Fulvestrant 67 SPRYCEL ® 67 chemosensitizer 67 ATL# [001] 67 Ecallantide 67 Meets Primary Endpoint 67 relapsed leukemia 67 vidofludimus 67 anti inflammatory NSAID 67 Zorbtive TM 67 SNT MC# 67 BENLYSTA TM 67 Patients Treated With 67 selective phosphodiesterase 67 itraconazole Sporanox 67 RELOVAIR ™ 67 Interferon alpha 67 novel VDA molecule 67 recurrent metastatic 67 vinorelbine tartrate 67 rabeprazole 67 comparator arm 67 imatinib Gleevec ® 67 Triapine R 67 Serostim ® 67 interferon gamma 1b 67 Cloretazine ® 67 OvaRex ® MAb 67 novel therapeutic antibodies 67 cisplatin gemcitabine 67 EndoTAG 67 intranasal formulation 67 lenalidomide dexamethasone 67 chronic eosinophilic leukemia 67 ELACYT 67 immunomodulatory therapy 67 mertansine 67 Kamada AAT 67 Tezampanel 67 Telintra 67 Roche Actemra 67 Simulect 67 metastatic malignant 67 proteasome inhibitor 67 Proquin XR 67 Liprotamase 67 acetonide FA 67 Dementia Related Psychosis 67 antibody MAb 67 pediatric acute lymphoblastic 67 PTK# 67 compound INCB# 67 Aurora Kinase 67 mitoxantrone plus 67 bevacizumab Avastin R 67 oral rivaroxaban 67 DermaVir Patch 67 oxymorphone ER 67 candidates Dyloject TM 67 TRO# 67 CTAP# Capsules 67 hyaluronidase enzyme 67 Pfizer Camptosar 67 Cloretazine 67 GVAX ® 67 MVA HPV IL2 67 R lenalidomide 67 TACI Ig 67 UPLYSO 67 AVASTIN 67 headache nasopharyngitis 67 Vitrasert R 67 ergot derivatives 67 Phase 1b clinical trials 67 Akt inhibitor 67 CYT# QbG# 67 pregabalin Lyrica 67 dextromethorphan quinidine 67 liposomal amphotericin B 67 Elvitegravir 67 ruxolitinib 67 5 fluorouracil leucovorin 66 Ostabolin C TM 66 lenalidomide Revlimid 66 inhaled liposomal ciprofloxacin 66 TNF Tumor Necrosis Factor 66 pralatrexate injection folate analogue 66 tumor xenograft models 66 receptor inhibitor 66 TELINTRA 66 DIFICID ™ 66 PrevOnco 66 Tesmilifene 66 non porcine pancreatic 66 Copegus ® 66 multitargeted 66 Lodotra TM 66 Aplidin 66 methylnaltrexone bromide 66 Factor VIIa 66 sunitinib Sutent 66 Evoltra ® 66 metastatic pancreatic 66 genotypic resistance 66 Zolpimist ™ 66 oral proteasome inhibitor 66 TLK# 66 denileukin diftitox 66 PEGylated anti 66 R Saizen R 66 ZOLINZA 66 Certolizumab pegol 66 lenalidomide Revlimid R 66 M# rationally 66 paclitaxel Taxol ® 66 SILENOR 66 CIMZIA TM certolizumab pegol 66 brivanib 66 metastatic hormone refractory 66 PRN FDA Approves 66 histone deacetylase HDAC inhibitor 66 SPECIFICS Cotton Valley 66 collagen vascular 66 kidney urologic 66 erlotinib Tarceva 66 LHRH receptor positive 66 hyperplasia BPH 66 Ixempra 66 AVAPRO 66 deCODE ProstateCancer TM 66 e antigen HBeAg 66 anthracyclines taxanes 66 PANVAC VF 66 Anti Factor VIII 66 oral ridaforolimus 66 Omnitarg 66 PEGylated interferon beta 1a 66 demonstrated antitumor activity 66 Antiangiogenic 66 THR beta agonist 66 Trastuzumab DM1 66 psoriasis rheumatoid arthritis 66 beta secretase inhibitors 66 alvespimycin 66 product Fentanyl TAIFUN 66 EDEMA3 trial 66 immunomodulatory agents 66 docetaxel Taxotere ® 66 anti CD3 monoclonal 66 posaconazole 66 sunitinib Sutent ® 66 YONDELIS R 66 Combination REOLYSIN R 66 HyperAcute 66 valtorcitabine 66 R sorafenib tablets 66 teriflunomide 66 BRAF inhibitor 66 Sudhir Agrawal D.Phil 66 Tarceva TM 66 Temodar ® 66 Zemplar Capsules 66 constipation OIC 66 adalimumab Humira 66 systemic anaplastic large 66 Irinotecan 66 Fingolimod 66 Uvidem 66 metastatic bladder 66 TO AVOID PREGNANCY WHILE 66 selective immunoproteasome inhibitor 66 TBC# 66 reduce serum phosphate 66 midstage clinical 66 huC# DM4 66 Glufosfamide 66 phase IIb study 66 Fludarabine 66 Phase IIb clinical trials 66 BRAF mutant 66 Pirfenidone 66 nilotinib Tasigna ® 66 Phase IIb trials 66 Laquinimod 66 Anidulafungin 66 orally inhaled migraine 66 pertuzumab 66 Bevacizumab Avastin 66 Anthracycline 66 PI3K/Akt pathway inhibitor 66 AKT inhibitor 66 Ixabepilone 66 refractory colorectal cancer 66 prokinetic agent 66 metastatic renal 66 gemcitabine cisplatin 66 Neuvenge 66 ErbB2 positive 66 catheter occlusion 66 oral picoplatin 66 cannabinor 66 metastatic castration resistant 66 recurrent glioblastoma multiforme 66 selective modulator 66 progressive metastatic prostate 66 Nexavar sorafenib 66 oropharyngeal candidiasis OPC 66 TRIOLEX HE# APOPTONE HE# 66 volociximab 66 VNP#M 66 Onconase 66 Adjuvant Treatment 66 Hsp# Inhibitor 66 Pertuzumab 66 Troxatyl 66 Commonly prescribed 66 tolevamer 66 Multiple Ascending Dose 66 Tasimelteon 66 adriamycin 66 HCl Tablets 66 bortezomib Velcade R 66 myeloproliferative neoplasms MPNs 66 Squalamine 66 evaluating tivozanib 66 NS5b 66 Shows Statistically Significant 66 ALK inhibitors 66 fusion enhancers 66 MGN# 66 candidate deforolimus 66 octreotide acetate 66 Vertex hepatitis C 66 herpetic keratitis 66 Cloretazine VNP#M 66 ABLYNX 66 Enkephalin 66 CCR5 receptor antagonist 66 Vandetanib 66 OvaRex R 66 pharmacokinetic interactions 65 novel emulsion formulation 65 Exelixis compounds 65 dopamine partial agonist 65 Remicade infliximab 65 cathepsin K inhibitor 65 aMCI precursor 65 TMC# [002] 65 immunotherapeutic vaccine 65 K ras mutations 65 Investigational Oral 65 Interferon beta 1a 65 candesartan cilexetil 65 pan histone deacetylase 65 Plaquenil 65 Cancidas 65 huN# DM1 65 Muraglitazar 65 Detrol Detrol LA 65 miconazole Lauriad ® 65 Copegus ribavirin 65 Budesonide foam crofelemer 65 FOLFOX6 chemotherapy regimen 65 RezularTM 65 Xcytrin R 65 Completes Patient Enrollment 65 aurora kinase 65 Prednisone Against Refractory 65 acyclovir Lauriad R 65 MyVax R 65 PDX pralatrexate 65 Aryplase 65 clevidipine 65 alendronate Fosamax 65 Phase 2b Clinical Trial 65 hypereosinophilic syndrome 65 Aptivus ® 65 Allovectin 7 65 evaluating Actimmune 65 iobenguane 65 PLX STROKE targeting 65 IgG1 monoclonal antibody 65 Liposomal 65 Phase Ib clinical trials 65 assessing T DM1 65 abacavir lamivudine 65 Bayer Nexavar 65 PGL# 65 ELND-#/AZD-# 65 glatiramer 65 memantine HCl 65 Zarnestra 65 Natalizumab 65 Angiotensin Converting Enzyme 65 Cardium Therapeutics TM 65 adenosine injection 65 Monoclonal antibody 65 ixabepilone 65 radezolid 65 vinca alkaloid 65 Campath alemtuzumab 65 Lubiprostone 65 Allovectin 7 ® 65 polyglutamate 65 Panzem NCD 65 Sphingomab TM 65 Pruvel 65 HCV NS5B polymerase 65 capecitabine Xeloda 65 Medoxomil 65 Sapacitabine 65 BAY #-# 65 Zenvia ™ 65 Tramiprosate ALZHEMED TM 65 Initiate Phase 65 Kahalalide F 65 pegylated liposomal doxorubicin 65 J Am Coll 65 biliary tract cancer 65 Belimumab 65 Fluticasone 65 Alocrest 65 Kuvan R 65 Bosutinib 65 sargramostim 65 epigenetic therapies 65 oral dual endothelin 65 SPL# Gel vaginal microbicide 65 small molecule tyrosine 65 Granulocyte Colony Stimulating Factor 65 TNF blocker therapy 65 chronic thromboembolic pulmonary 65 Verstovsek 65 personalized cellular immunotherapy 65 unresectable tumors 65 Atripla combines 65 regorafenib 65 PDE# inhibitors 65 5 HT2A inverse 65 Hedgehog Pathway Inhibitor 65 Mycophenolate Mofetil 65 Roflumilast 65 aripiprazole Abilify 65 IMiDs R 65 ASONEP ™ 65 COPEGUS R 65 Pruvel TM 65 TASKi2 65 Phase 2a Clinical Trial 65 small molecule chemotherapeutic 65 interferon alpha IFN 65 pharmacologically active isomer 65 tanespimycin 65 FOLOTYN ® 65 JAK2 inhibitor 65 Capecitabine 65 Virulizin ® 65 HBeAg negative 65 incyclinide 65 TKB# 65 Lenalidomide 65 forodesine 65 HMG CoA reductase inhibitors 65 IMiDs ® compound 65 Epothilones 65 ® lenalidomide 65 Actonel risedronate 65 sunitinib malate 65 brivaracetam 65 renin inhibitors 65 Tanespimycin 65 intravesical infusion therapy 65 small molecule thrombopoietin 65 Vectibix panitumumab 65 Submits NDA 65 Vascular Disrupting Agent 65 microtubule inhibitor 65 Pemetrexed 65 BLP# Liposome Vaccine 65 evaluating picoplatin 65 micafungin 65 Parathyroid Hormone 65 Trovax 65 MCSP respectively 65 metaglidasen 65 Atypical Hemolytic Uremic Syndrome 65 FUSILEV ® 65 neutropenia dehydration dyspnea 65 Metastatic Melanoma 65 cromolyn sodium 65 Thiovir 65 Saxagliptin 65 antiangiogenic agent 65 Boniva ibandronate 65 Investigational Treatment 65 Solazed 65 Enzastaurin 65 ZACTIMA 65 generation antisense inhibitor 65 rheumatoid arthritis inflammatory bowel 65 accumulate preferentially 65 mGluR2 positive 65 XP# XP# 65 estramustine 65 milnacipran HCl 65 Panzem ® 65 Fluorouracil 65 Kepivance 65 5 HT4 65 subcutaneous immunoglobulin 65 albiglutide 65 Romidepsin 65 psoriasis Crohn disease 65 follicular Non Hodgkin 65 oxaliplatin Eloxatin 65 cetrorelix pamoate 65 HBeAg + 65 Acute Exacerbations 65 Teriflunomide 65 Genasense ® 65 GRNVAC1 65 KSP inhibitor 65 Pegylated interferon 65 Phase 2b Trial 65 non constipating irritable 65 pancreatic enzyme replacement 65 efaproxiral 65 induce orthostatic hypotension 65 IBS C 65 Romiplostim 65 pamidronate 65 MVA MUC1 IL2 65 trastuzumab Herceptin ® 65 MGd 65 Clolar ® 65 diabetic neuropathic pain 65 allosteric modulator PAM 65 Voreloxin 65 brand ciclesonide HFA 65 tuberous sclerosis TS 65 Albugon 65 Initiates Clinical Trial 65 inhaled AAT 65 patientswith 65 HIV coinfected 65 Recombinant Human 65 IMC #B 65 mGluR2 NAM 65 Carvedilol 65 Pimavanserin 64 Xyfid TM 64 PSN# [002] 64 Proxinium TM 64 MIRAPEX ER 64 targeted antifolate 64 Xelox 64 highly selective inhibitor 64 Valopicitabine 64 Sanofi Aventis Taxotere 64 lamotrigine Lamictal 64 Adjuvant therapy 64 Dosa suffers 64 antimetabolite 64 sodium glucose cotransporter 64 maximally tolerated 64 Cardiotoxicity 64 TELINTRA R 64 oncolytic virus therapies 64 antibody MT# 64 non resectable metastatic 64 Phase IIb Trial 64 somatostatin analogue 64 Tasigna prolongs 64 ularitide 64 BRILINTA 64 rHuEPO 64 Zolinza 64 T1c 64 pharmacodynamic properties 64 Spiegelmer ® 64 VEGFR2 inhibitor 64 STELARA TM 64 metastatic gastric 64 Danazol 64 Inhalation Solution 64 valopicitabine NM# 64 lintuzumab SGN 64 BCR ABL inhibitors 64 Bayer Onyx 64 DCCR 64 Angiocept 64 IMPDH inhibitor 64 Late Breaker 64 AEG# 64 GSK# [002] 64 PEGINTRON TM 64 Darinaparsin 64 SUTENT ® 64 Dr. McHutchison 64 Xatral R 64 Bazedoxifene 64 Refractory Hodgkin Lymphoma 64 INVEGA ® 64 liposomal formulation 64 Microwave Ablation System 64 plus DOXIL 64 BRIM2 64 Entocort 64 Urocidin TM 64 Orally administered 64 Nexavar ® 64 delta gamma agonist 64 Onalta ™ 64 muscarinic receptor agonist 64 Phase #b/#a trial 64 Bayer HealthCare Onyx Pharmaceuticals 64 lymphoproliferative disorders 64 ULTRASE 64 Oglemilast 64 riociguat 64 Deferiprone 64 Lenocta TM 64 Sustiva efavirenz 64 EOquin TM 64 multi kinase inhibitor 64 ® bortezomib 64 Zemiva TM 64 RH1 64 NS5B polymerase 64 immunotherapeutic approaches 64 BENICAR HCT 64 DOXIL 64 IGF 1R inhibitor 64 PD LID 64 Schering Plough Remicade 64 antiangiogenic therapy 64 Tykerb lapatinib 64 basal insulin analogue 64 paclitaxel Taxol R 64 anthracycline containing 64 Fenretinide 64 DPX Survivac 64 Doxil ® 64 radiation sensitizer 64 immunotoxin 64 Phase IIa trials 64 anti angiogenic agents 64 MAb therapy 64 Degarelix 64 selectively inhibited 64 Kinoid 64 gets USFDA nod 64 5 HT2A serotonin 64 bowel syndrome IBS 64 registrational trial 64 Deforolimus 64 immune modulating 64 Silodosin 64 MOVIPREP R 64 CYP#A# CYP#D# 64 candidate epratuzumab 64 deforolimus 64 Dalbavancin 64 treat benign prostatic 64 MoxDuo ® 64 Orencia abatacept 64 Cimzia TM 64 Proellex TM 64 bladder ovarian 64 Advagraf 64 GSK# [001] 64 PHASE III 64 Gemzar gemcitabine 64 liposomal doxorubicin 64 Solazed TM 64 oral antiviral 64 opioid naive 64 mesylate 64 Tipranavir 64 DU #b 64 Tyrima 64 Alessandro Riva 64 BAL# [002] 64 myeloproliferative disorders 64 BYETTA exenatide injection 64 Xcellerated T Cells 64 Complicated Skin 64 vaginal candidiasis 64 ADP receptor antagonist 64 AGILECT R 64 MAXY alpha 64 AMEVIVE 64 HCV polymerase inhibitors 64 topically applied SEPA 64 lymphoid malignancies 64 Epirubicin 64 Aurexis R 64 stage IIIb IV 64 ATACAND 64 long acting muscarinic 64 Interferon alfa 64 triggers apoptosis programmed 64 uremic pruritus 64 C1 INH deficiency 64 Posaconazole 64 Amplimexon 64 Ambrisentan 64 antiepileptics 64 #mg #mg #mg [003] 64 Sebivo 64 Aplidin R 64 ACTEMRA TM 64 Pradefovir 64 Initiates Enrollment 64 Ostarine ™ 64 neuropathy sparing 64 phase IIb clinical 64 Copegus R 64 Warner Chilcott Actonel 64 receptor inhibiting monoclonal 64 MKC# 64 oral talactoferrin 64 non nucleoside HCV 64 Aceon 64 bovine thrombin 64 CA9 SCAN 64 p# inhibitor 64 CDK cyclin dependent 64 VANTAS ® 64 hereditary emphysema 64 SAR# [002] 64 PEG IFN 64 Fibrillex TM 64 Myelodysplastic Syndrome MDS 64 LEUKINE 64 Empatic ™ 64 Naive Patients 64 DAVANAT 64 Preclinical studies suggest 64 intravenous cyclophosphamide 64 Talabostat 64 Hydrochlorothiazide Tablets 64 developing Bicifadine serotonin 64 potent antiproliferative 64 dihydrochloride Tablets 64 iSONEP ™ 64 investigational monoclonal antibody 64 omega interferon 64 REMINYL ® 64 Therapeutic Vaccine 64 SNT-MC#/idebenone 64 GSK '# 64 Febuxostat 64 ovarian cancer chronic hepatitis 64 Paraplatin ® 64 infectious diseases autoimmune diseases 64 Pegylated Interferon 64 NPC 1C 64 zoledronate 64 By JENNIFER LEARN 64 BCG refractory carcinoma 64 docetaxel Taxotere R 64 ALVESCO R 64 investigational oral hepatitis C 64 OMAPRO ™ 64 BCR ABL inhibitor 64 Nanobody 64 receptor modulators 64 XL# XL# 64 rasagiline tablets 64 radiation enteritis 64 sitaxsentan 64 CDK inhibitor 64 alpha 2a 64 nalbuphine ER 64 IRX 2 64 neratinib 64 estrogen receptor antagonist 64 ritonavir boosted 64 nucleotide analogue 64 pioglitazone HCl 64 lumiliximab 64 refractory metastatic 64 delivers fluocinolone acetonide FA 64 leukemia multiple myeloma 64 Successfully Completes Phase 64 Chemokine Receptor 64 XL# XL# XL# XL# 64 osteolytic bone disease 64 TYGACIL 64 XYOTAX TM 64 fostamatinib 64 Monopril 64 dexamethasone Decadron 64 abatacept Orencia 64 Pazopanib 64 EGS# 64 colorectal lung 64 CYT# vascular disrupting 64 NOX E# 64 TKM ApoB 64 enzastaurin 64 INS# [001] 64 taxane resistant 64 R MSCRAMM 64 Femara letrozole 64 Specifid 64 CIMZIA ™ 64 plus prednisone prednisolone 64 dihydrochloride 64 class mGluR5 inhibitor 64 Cannabinor 64 JAK inhibitors 64 Ozarelix 64 sJIA 64 BrachySil TM 64 sarcoma melanoma 64 novel synthetic peptide 64 Dose Ranging Study 64 Initiates Phase III 64 Traficet EN 64 Fosamax alendronate 64 LAB CGRP 64 polysaccharide polymer 64 TransVax 64 MEK Inhibitor 64 aplindore 64 Roche Herceptin 64 molecular imaging radiopharmaceutical 64 bosentan Tracleer 64 investigational integrase inhibitor 64 fluconazole resistant 64 Ovitrelle R Serostim 64 hypertrichosis occurred 64 Ostabolin C 64 investigational protease inhibitor 64 Neoadjuvant 64 seliciclib CYC# 64 cystinosis patients 64 Mestinon 64 Soft Tissue Sarcoma 64 G#DT 64 Sandostatin 64 sublingual tablets 64 palifermin 64 calcineurin inhibitors 64 Valtropin 64 interferon beta therapy 64 docetaxel Taxotere 64 Anti VEGF 64 Adenosine A2A 64 multiple sclerosis Crohn disease 64 Arranon 64 hormone refractory metastatic prostate 64 Drug Candidate 64 ANTEGREN 64 immunomodulatory properties 64 maximally tolerated dose 64 post herpetic 63 Diamyd ® 63 NU# direct 63 Phase 2b clinical trials 63 JAK2 Inhibitor 63 Ribavirin causes 63 Interferon beta 1b 63 Elotuzumab 63 advanced hepatocellular carcinoma 63 BEMA TM Fentanyl 63 PEG interferon 63 Clevudine 63 interleukin IL -# 63 compound perifosine 63 IMiDs 63 antimitotic 63 selective S#P# receptor agonist 63 Chronic lymphocytic leukemia 63 PNT# 63 INCB# [001] 63 CINQUIL 63 tigecycline 63 RNA antagonist 63 haematologic 63 protein tyrosine phosphatase 1B 63 fluoropyrimidine 63 induced macular edema 63 anti angiogenic agent 63 carcinoma HCC 63 essential thrombocythemia 63 Junovan TM 63 Captisol enabled 63 candidates Azedra TM 63 beta interferons 63 Moxifloxacin 63 EndoTAG TM 63 chimeric monoclonal antibody 63 histone deacetylase inhibitor 63 See CLINICAL PHARMACOLOGY 63 Camptosar ® 63 Zenapax 63 selective A2A adenosine receptor 63 Taclonex R 63 commercialize deforolimus 63 metastatic colorectal 63 Intravitreal 63 ofatumumab HuMax CD# 63 coadministration 63 Telatinib 63 FASLODEX 63 peripherally acting 63 Oracea TM 63 Ridaforolimus 63 Soliris TM eculizumab 63 taxane refractory 63 docetaxel Injection Concentrate 63 Janus kinase 63 pediatric Crohn disease 63 Navelbine ® 63 midstage trials 63 DP VPA 63 Epothilone D 63 ORENCIA ® 63 evaluating satraplatin plus 63 platelet inhibitor 63 ALN HPN 63 sapacitabine CYC# 63 HoFH 63 Urocidin 63 erlotinib Tarceva R 63 CIMZIA TM 63 Zybrestat 63 esomeprazole Nexium 63 Afatinib 63 torsemide ER 63 Stage IIIb 63 administered intranasally 63 fusion inhibitor 63 biologic DMARD 63 Viread tenofovir disoproxil fumarate 63 markets HP Acthar 63 HQK 63 AE# vaccine 63 busulfan 63 fosbretabulin 63 CCR9 antagonist 63 Lymphocytic 63 EDEMA3 63 pentadentate logo R 63 IAP inhibitors 63 evaluating T DM1 63 JAK3 inhibitor 63 gastrointestinal stromal 63 alfa 2a 63 cytarabine daunorubicin 63 polymerase inhibitor 63 vismodegib 63 Relapsed Refractory Multiple Myeloma 63 Apoptone 63 multicenter Phase II 63 Iloperidone 63 epithelial tumors 63 ThermoDox R 63 HSP# inhibitor 63 overactive bladder VANTAS 63 oral immunomodulatory 63 hylan GF 63 Familial Adenomatous Polyposis FAP 63 metastatic androgen independent 63 malignant ascites 63 CYP#A# substrate 63 headache abdominal pain